O'Rourke & Company’s State Street Health Care Select Sector SPDR ETF XLV Stock Holding History

O'Rourke & Company’s Portfolio XLV Stock Details XLV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.24M	Buy	7,796 +6,191	+386%	+$921K	0.43%	56
2026 Q1	$1.11M	Sell	1,605 -5,744	-78%	-$886K	0.44%	57
2025 Q4	$1.14M	Buy	7,349 +360	+5%	+$53.9K	0.44%	54
2025 Q3	$973K	Sell	6,989 -80	-1%	-$10.8K	0.41%	54
2025 Q2	$953K	Buy	7,069 +1,578	+29%	+$213K	0.44%	53
2025 Q1	$802K	Buy	5,491 +7	+0.1%	+$1.02K	0.4%	59
2024 Q4	$754K	Sell	5,484 -333	-6%	-$48.7K	0.37%	60
2024 Q3	$896K	Sell	5,817 -179	-3%	-$27.1K	0.45%	50
2024 Q2	$874K	Buy	5,996 +282	+5%	+$40.5K	0.49%	45
2024 Q1	$844K	Buy	5,714 +595	+12%	+$85.4K	0.49%	47
2023 Q4	$698K	Sell	5,119 -128	-2%	-$16.7K	0.45%	51
2023 Q3	$675K	Buy	5,247 +239	+5%	+$31.7K	0.49%	46
2023 Q2	$665K	Sell	5,008 -4	-0.1%	-$527	0.47%	50
2023 Q1	$649K	Sell	5,012 -574	-10%	-$75K	0.49%	51
2022 Q4	$759K	Buy	5,586 +21	+0.4%	+$2.78K	0.6%	45
2022 Q3	$674K	Buy	5,565 +265	+5%	+$34.1K	0.59%	44
2022 Q2	$680K	Sell	5,300 -7	-0.1%	-$918	0.58%	46
2022 Q1	$727K	Buy	5,307 +77	+1%	+$10.2K	0.5%	48
2021 Q4	$737K	Buy	+5,230	New	+$694K	0.49%	47

Other funds holding XLV

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

O'Rourke & Company's XLV Position: Q2 2026 in Review

O'Rourke & Company increased its State Street Health Care Select Sector SPDR ETF (XLV) stake by 386% in Q2 2026, buying an estimated $921K and bringing the position to 7,796 shares worth $1.24M. The position accounts for 0.43% of the portfolio, ranked #56.

O'Rourke & Company first reported a position in XLV in Q4 2021 and has held it in 19 quarters since. 1,856 funds tracked by Wall St. Rank hold XLV as of Q2 2026.

O'Rourke & Company held 7,796 shares of State Street Health Care Select Sector SPDR ETF worth $1.24M as of Q2 2026.
O'Rourke & Company bought 6,191 State Street Health Care Select Sector SPDR ETF shares in Q2 2026, an estimated $921K.
State Street Health Care Select Sector SPDR ETF made up 0.43% of O'Rourke & Company's portfolio in Q2 2026, its #56 holding.
O'Rourke & Company first reported a position in State Street Health Care Select Sector SPDR ETF in Q4 2021 and has held it in 19 quarters since.
1,856 funds tracked by Wall St. Rank held State Street Health Care Select Sector SPDR ETF as of Q2 2026.

Based on O'Rourke & Company's 13F filing for Q2 2026, filed 14 Aug 2026.